Frequency of Pulmonary Tuberculosis in Patients with Cutaneous Diseases taking Oral Steroid Therapy

Authors

  • Muhammad Zulqarnain Haider Khan Nishtar Hospital, Multan, Pakistan
  • Muhammad Shahid Nawaz Khan Nishtar Hospital, Multan, Pakistan
  • Farah Sattar Nishtar Hospital, Multan, Pakistan
  • Shamshad Akram Nishtar Hospital, Multan, Pakistan
  • Esiha-Tir Razia Nishtar Hospital, Multan, Pakistan
  • Asma Bano Nishtar Hospital, Multan, Pakistan

DOI:

https://doi.org/10.61581/MJSP.VOL01/01/04

Keywords:

Cutaneous diseases, systemic steroids, pulmonary tuberculosis, Mycobacterium, sputum smear

Abstract

Objective: to investigate the frequency of pulmonary tuberculosis in patients of cutaneous diseases requiring high dose steroids therapy.

Study Design: Cross sectional study Place and duration: Dermatology department of Nishtar Hospital Multan in one year duration from 2nd March 2018 to 2nd March 2019.

Methodology: Sixty patients currently diagnosed with skin manifestations and taking high dose steroids were screened for pulmonary tuberculosis. Patients were screened at 6 weeks, 3 months and 6 months. Chest radiograph, sputum smear for acid fast bacilli and sputum culture were performed at every visit. SPSS version 23 was used for analysis of data and test of significance.

Results: Sputum smear at 6 weeks, 3 months and 6 months was observed as 1.6%, 3.3% and 6.6%, respectively. Sputum culture at 6 weeks, 3 months and 6 months was observed as 11.6%, 13.3% and 10%, respectively. X-Ray at 6 weeks, 3 months and 6 months was observed as 1.6%, 0% and 0%, respectively.

Conclusion: Patients with cutaneous diseases taking systemic steroids should screen for pulmonary diseases at intervals because they can develop pulmonary tuberculosis.

Downloads

Published

29-01-2020

Issue

Vol. 1 No. 1 (2020): Medical Journal of South Punjab

Section

Medical Section

License

Copyright (c) 2020 Muhammad Zulqarnain Haider Khan, Muhammad Shahid Nawaz Khan, Farah Sattar, Shamshad Akram, Esiha-Tir Razia, Asma Bano

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.